Antiretrovirals and Risk of COVID-19 Diagnosis and Hospitalization in HIV-Positive Persons

The risk of COVID-19 diagnosis and hospitalization among HIV-positive individuals is lower in those receiving treatment with TDF/FTC than in those receiving other ART regimes. This association does not seem to be explained by confounding due to unmeasured clinical characteristics. Our finding is com...

Descripción completa

Detalles Bibliográficos
Autores: del Amo, Julia, Polo, Rosa, Moreno, Santiago, Díaz, Asunción, Martínez, Esteban, Arribas, José Ramón, Jarrín, Inma, Hernán, Miguel A.
Tipo de recurso: artículo
Fecha de publicación:2020
País:España
Institución:Servizo Galego de Saúde (SERGAS)
Repositorio:RUNA. Repositorio da Consellería de Sanidade e Sergas
OAI Identifier:oai:runa.sergas.gal:20.500.11940/15661
Acceso en línea:https://pubmed.ncbi.nlm.nih.gov/32773469/
http://hdl.handle.net/20.500.11940/15661
Access Level:acceso abierto
Palabra clave:Risk
Integrase Inhibitors
Cooperative Behavior
HIV
Incidence
VIH
incidencia
conducta cooperativa
riesgo
inhibidores de la integrasa
CHUF
CHUS
CHUVI
CHUAC
Descripción
Sumario:The risk of COVID-19 diagnosis and hospitalization among HIV-positive individuals is lower in those receiving treatment with TDF/FTC than in those receiving other ART regimes. This association does not seem to be explained by confounding due to unmeasured clinical characteristics. Our finding is compatible with accumulating evidence on a potential effect of TDF/FTC against SARS-CoV-2 infection.

Similares en LA Referencia